clorazepate dipotassium has been researched along with diphenhydramine in 1 studies
Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (diphenhydramine) | Trials (diphenhydramine) | Recent Studies (post-2010) (diphenhydramine) |
---|---|---|---|---|---|
325 | 90 | 11 | 4,146 | 415 | 542 |
Protein | Taxonomy | clorazepate dipotassium (IC50) | diphenhydramine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.98 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.542 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 1.05 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.372 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.162 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.346 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.647 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.542 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 1.295 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.98 | |
Histamine H1 receptor | Homo sapiens (human) | 0.171 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.118 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.8852 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azab, M; Ben Amor, B; Culine, S; Droz, JP; Ghosn, M; Lupera, H; Pietri, F; Renaux, J; Theodore, C | 1 |
1 trial(s) available for clorazepate dipotassium and diphenhydramine
Article | Year |
---|---|
[A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin].
Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Clorazepate Dipotassium; Cosyntropin; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Therapy, Combination; Humans; Metoclopramide; Middle Aged; Neoplasms; Prospective Studies; Vomiting | 1989 |